Cognitive functioning in patients treated with electroconvulsive therapy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10383443" target="_blank" >RIV/00216208:11110/18:10383443 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/18:10383443

Výsledek na webu

<a href="https://doi.org/10.2147/NDT.S182423" target="_blank" >https://doi.org/10.2147/NDT.S182423</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2147/NDT.S182423" target="_blank" >10.2147/NDT.S182423</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Cognitive functioning in patients treated with electroconvulsive therapy

Popis výsledku v původním jazyce

Background: Electroconvulsive therapy (ECT) is an effective treatment method for severe mental illnesses. ECT has gone through significant modernization. Side effects of ECT have largely decreased. Temporary disturbance of cognitive performance can be still present as a side effect of electroconvulsive treatment. Methods: Cognitive functioning in the sample of patients with severe and acute mental illness treated with electroconvulsive therapy (ECT) was assessed. Basic assessment of cognitive functions was applied in the beginning, in the middle, and at the end of ECT course treatment with the Montreal Cognitive Assessment (MoCA). Complex and detailed testing of cognitive functions using the MATRICS Consensus Cognitive Battery (MCC B) was done at two points in time within the first week of and then 6 weeks after the end of ECT. Results: Participants had cognitive deficits at baseline, which were most likely influenced markedly by the psychopathology of the illness itself. The improvement in cognition came together with the reduction in psychopathology; psychopathology scores were significantly reduced during ECT treatment. Compared to the baseline, all scores for cognitive testing were significantly improved but remained low in comparison with the controls. After 6 weeks, there was further significant improvement. Conclusion: Our results confirm the safety and efficacy of ECT in the treatment of severe mental disorders.

Název v anglickém jazyce

Cognitive functioning in patients treated with electroconvulsive therapy

Popis výsledku anglicky

Background: Electroconvulsive therapy (ECT) is an effective treatment method for severe mental illnesses. ECT has gone through significant modernization. Side effects of ECT have largely decreased. Temporary disturbance of cognitive performance can be still present as a side effect of electroconvulsive treatment. Methods: Cognitive functioning in the sample of patients with severe and acute mental illness treated with electroconvulsive therapy (ECT) was assessed. Basic assessment of cognitive functions was applied in the beginning, in the middle, and at the end of ECT course treatment with the Montreal Cognitive Assessment (MoCA). Complex and detailed testing of cognitive functions using the MATRICS Consensus Cognitive Battery (MCC B) was done at two points in time within the first week of and then 6 weeks after the end of ECT. Results: Participants had cognitive deficits at baseline, which were most likely influenced markedly by the psychopathology of the illness itself. The improvement in cognition came together with the reduction in psychopathology; psychopathology scores were significantly reduced during ECT treatment. Compared to the baseline, all scores for cognitive testing were significantly improved but remained low in comparison with the controls. After 6 weeks, there was further significant improvement. Conclusion: Our results confirm the safety and efficacy of ECT in the treatment of severe mental disorders.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30215 - Psychiatry

Projekt

<a href="/cs/project/NV15-30439A" target="_blank" >NV15-30439A: Sledování možných faktorů ovlivňujících používání elektrokonvulzivní terapie (ECT) v psychiatrii.</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Neuropsychiatric Disease and Treatment

ISSN

1178-2021

e-ISSN

—

Svazek periodika

14

Číslo periodika v rámci svazku

November

Stát vydavatele periodika

NZ - Nový Zéland

Počet stran výsledku

7

Strana od-do

3025-3031

Kód UT WoS článku

000450296500004

EID výsledku v databázi Scopus

2-s2.0-85057541125